XNCR Message Board Post 9843208 | Xencor Inc.
home / stock / xncr / xncr message board
dontknow
(investorshub)
Posted on: Dec/16/2013 00:05:07
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=94990168
Non-hodgekins lymphoma, asthma, and lupous are pretty good
News, Short Squeeze, Breakout and More Instantly...
-
2024-07-05 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, announced it will regain exclusive worldwide rights to plamotamab, a CD20 x CD3 bispecific T-cell engager, which Xencor advanced through ...
-
2024-06-04 04:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...